by Julia Lloyd, MPH, RD, LDN, CDCES
Spring 2026
GLP-1 medications are changing how people manage weight, blood sugar and metabolic health. For many, they reduce hunger and constant food thoughts. That relief can feel freeing and improve daily life. For people with a history of dieting or disordered eating, however, reduced appetite may also raise concerns about maintaining adequate nutrition or navigating past challenges with food.
This article explains how GLP-1 medications work, potential nutrition risks that may arise with a low appetite, warning signs to watch for and how care teams can help protect both health and recovery.
These terms sound similar but have different meanings.
Because dieting can lead to disordered eating, and disordered eating can develop into an eating disorder, healthcare teams should screen for past or current harmful food-related thoughts before starting treatments that affect appetite, including GLP-1 therapy. If a restrictive eating disorder is present, GLP-1 treatment is generally not recommended without specialist input.
It can be difficult to tell the difference between expected appetite changes and concerning behaviors with GLP-1 use. Contact your healthcare team if you notice:
If you have a history of an eating disorder, pay attention to your internal voice and notice concerning thoughts early. Regular visits with a mental health professional are recommended.
GLP-1 is a natural digestive hormone released when you eat. GLP-1 medications mimic this hormone but last longer and act on both the brain and stomach. They lower levels of the hunger hormone ghrelin, which can reduce cravings, mindless eating and bingeing. They also slow gastric emptying, so food stays in the stomach longer.
Many people feel full sooner, stay satisfied longer and think less about food. For those who struggle with constant hunger and food thoughts, this can feel freeing and help improve their relationship with food.
However, the goal is improved appetite signaling, not eating as little as possible. During the first weeks or months, some people unintentionally under-eat as their body adjusts. They may forget to eat because hunger cues are weaker or lose interest in foods they once enjoyed.
Extended under-eating can lead to nutrient gaps and other health concerns. Most risks can be prevented or reduced with awareness and support.
Contact your healthcare team if these challenges continue.
Working with a registered dietitian (RD or RDN) can support your relationship with food, prevent malnutrition and help manage side effects. Their role may include:
Using a GLP-1 medication safely while caring for your relationship with food is possible with coordinated support.
GLP-1 treatment is safest and most effective when prescribers, dietitians and mental health professionals work together. Prescribers monitor labs, adjust doses and screen for medical risks. Dietitians review eating patterns, provide nutrition counseling and help manage side effects. Mental health professionals guide patients through physical, mental and emotional changes while monitoring for new or returning disordered thoughts or behaviors. Clinical guidance also recommends referral to specialists for anyone with a history of eating disorders before starting GLP-1 therapy.
GLP-1 medications can quiet constant hunger and cravings, but they may also bring up past patterns of restriction. Safe use includes attending regular healthcare appointments, following dosing directions and staying nourished and hydrated to prevent nutrition gaps and side effects.
If you or someone you care for is starting or currently taking a GLP-1 medication and has concerns about disordered eating, ask for support from a dietitian and mental health professional. Obesity is a complex condition and benefits from coordinated care from a comprehensive healthcare team.
About the Author:
Julia Lloyd, MPH, RD, LDN, CDCES, is a registered dietitian and diabetes educator specializing in GLP-1 counseling. She is the founding dietitian of Alnu Health, where she helps train digital support tools designed to enhance obesity and cardiometabolic care between clinic visits. She serves on the Concierge Medicine and Executive Health teams at Massachusetts General Hospital in Boston and has contributed as an expert source to national media outlets including The New York Times. Read more of her work at Alnuhealth.com/blog.
Help the OAC to raise awareness, advocate for improved access, provide evidence-based education,
fight to eliminate weight bias and discrimination and elevate the conversation of weight and its impact on health.
by Sarah Muntel, RD Spring 2026 Nutritional needs change throughout life, from childhood to adolescence and into…
Read Articleby Audrey Wells, MD Spring 2026 Obstructive sleep apnea (OSA) and obesity often occur in the same…
Read Articleby Michelle “Shelly” Vicari, OAC Director of Programs Spring 2026 About 95% of teens have access to…
Read ArticleYour Support Fuels Education
Your donation helps OAC create high-quality education that supports real people on their health journeys.
Help us keep trusted, science-based resources free for everyone.

Access to this page required Community+ Membership.
Click Here to Learn More
Already have Community+ membership?
Click Here to Login
Or click here to go to our main page.